Dr. Haldorsen on the Importance of Imaging in the Diagnosis of Endometrial Cancer

Ingfrid Haldorsen, MD
Published: Thursday, Jan 11, 2018



Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the importance of imaging in the diagnosis of endometrial cancer.

Imaging in the primary diagnostic workup is extremely important in endometrial cancer, says Haldorsen. In addition to guiding the choice of surgical procedure or adjuvant therapy, it can provide knowledge of the tumor extent, as well as the aggressive features of the tumor, preoperatively or pre-therapeutically. This knowledge may aid in defining the intensity of treatment, Haldorsen adds.

For patients who may not need as aggressive of treatment, this is vital, as overtreatment often comes with added toxicities. In the era of precision medicine, utilizing tools, such as imaging can greatly assist in the individualization of treatment for patients with endometrial cancer.


Ingfrid Haldorsen, MD, University of Bergen, Haukeland University Hospital, discusses the importance of imaging in the diagnosis of endometrial cancer.

Imaging in the primary diagnostic workup is extremely important in endometrial cancer, says Haldorsen. In addition to guiding the choice of surgical procedure or adjuvant therapy, it can provide knowledge of the tumor extent, as well as the aggressive features of the tumor, preoperatively or pre-therapeutically. This knowledge may aid in defining the intensity of treatment, Haldorsen adds.

For patients who may not need as aggressive of treatment, this is vital, as overtreatment often comes with added toxicities. In the era of precision medicine, utilizing tools, such as imaging can greatly assist in the individualization of treatment for patients with endometrial cancer.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Oncology Best Practice™: Expert Perspectives to Incorporate Evidence on PARP Inhibitors into Practice and Optimize the Medical Management of Ovarian CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x